2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ : 2023-09-16
±³À°ÀÏÀÚ : 2023-09-16
±³À°Àå¼Ò : ¼¿ï ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ
±³À°ÁÖÁ¦ : 2023³â Á¦15ȸ ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽŰæ°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÅðÇ༺½Å°æÁúȯÇÐȸ
´ã´çÀÚ : ÀÌÇý¿ø
¿¬¶ôó : 042-600-6456
À̸ÞÀÏ : office.ksnd@gmail.com
±³À°Á¾·ù : ½Å°æ°ú
Âü¼®¿¹»óÀÎ : 250¸í
Èñ¸ÁÆòÁ¡ : 4Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 7 ½Ã°£ 40ºÐ
¼¼ºÎ¼ö°·á : 120,000¿ø
ºñ°í »çÀüµî·Ï(ÁØȸ¿ø 3¸¸¿ø, Á¤È¸¿ø/ÀÌ»çÁø 5¸¸¿ø), ´çÀϵî·Ï(ÁØȸ¿ø 5¸¸¿ø, Á¤È¸¿ø/ÀÌ»çÁø 7¸¸¿ø), ºñȸ¿ø(ÁØȸ¿ø±Þ 8¸¸¿ø, Á¤È¸¿ø±Þ 12¸¸¿ø)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:00~09:20 Registration ()
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:20~09:30 Opening Remark ¹¬ÀÎÈñ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:30~09:50 Recent advances in biomarkers and therapeutics for AD °í¼ºÈ£(ÇѾçÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 09:50~10:10 Updates in Parkinson ±èÇÑÁØ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:10~10:30 RNA-binding protein and phase separation in ALS ±è±â¿µ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:30~10:50 Recent trends in Alzheimer R&D ±è¿µ¼ö(¿¬¼¼´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 10:50~11:10 Current trends and challenges in basic and translational research in Parkinson¡¯s disease ÀÌ¿¬Á¾(¼º±Õ°üÀÇ´ë)
ÈÞ½Ä 09¿ù 16ÀÏ 11:10~11:20 Break ()
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 11:20~12:00 Development of patient-specific diagnosis and treatment for rare degenerative diseases: from bench to bedside ÃÖº´¿Á(¼º±Õ°üÀÇ´ë)
½Ä»ç 09¿ù 16ÀÏ 12:00~13:00 Á¡½É ½Ä»ç ()
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:00~13:20 HIFU-responsive multifunctional nanoparticle for the treatment of Parkinson¡¯s disease ±è¿øÁ¾(POSTECH)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:00~13:20 Acetylated tau: A missing link between brain injury and Alzheimer¡¯s disease ½Å¹Î±Ô(¼¿ï´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:20~13:40 Strategies for simulating and overcoming human blood-brain barrier ¹ÚÅÂÀº(UNIST)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:20~13:40 How do misfolded proteins cause neurodegenerative diseases?: from molecules to drug discovery ¹ÚÇýÁø(KAIST)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 13:40~14:00 BBB-bypassing transcranial route for brain drug delivery °í¿µÅ¹(°¡Ãµ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 13:40~14:00 Reciprocal relationship between biomolecular condensates and proteostasis ±Ç¿µ´ë(¼º±Õ°üÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 14:00~14:20 Super-selective brain delivery of a therapeutic antibody and its therapeutic application in AD ÀÌÀçö(IMNEWRUN)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 14:00~14:20 Functional brain organoid-based precision medicine platform for neurodegenerative diseases ¹ÚÁ¾Âù(¼º±Õ°ü´ë)
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ´ëȸÀÇ½Ç 14:20~15:00 Guided Poster Session ÇмúÀ§¿ø()
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:00~15:20 Applying genomics and transcriptomics for advancements in Alzheimer¡¯s disease research ¹Ú¿µÈ£(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:00~15:20 The evolving role of biomarkers in early and prodromal Parkinson¡¯s disease ÀÌÁö¿µ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:20~15:40 Anti-inflammatory clearance of amyloid beta for Alzheimer¡¯s disease ±èÂùÇõ(KAIST)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:20~15:40 Novel pathological model system for Parkinson¡¯s disease ¿À¿äÇÑ(ÇѾçÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 15:40~16:00 Phase-I clinical trial of antibody targeting lysine-280 acetylated tau for Alzheimer¡¯s disease À±½Â¿ë(¿ï»êÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 15:40~16:00 TGF¥â signaling in the pathogenesis and treatment of peripheral neuropathy È«¿µºó(µ¿¾ÆÀÇ´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 16:00~16:20 Regional amyloid-tau interaction model for Alzheimer¡¯s disease ¼ºÁØ°æ(°í·Á´ë)
±³À°½Ã°£ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 16:00~16:20 White matter matters: The role of glia in white matter degeneration ÀÌÇö°æ(Baylor College Med.)
ÈÞ½Ä 09¿ù 16ÀÏ 16:20~16:30 Break ()
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦA 16:30~17:20 Oral Presentation Session 1 ±èÀ±°æ(KIST)
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦB 16:30~17:20 Oral Presentation Session 2 ÀÌÈ£¿ø(°æºÏÀÇ´ë)
±âŸ 09¿ù 16ÀÏ ¹é¹ü±è±¸±â³ä°ü ÄÁº¥¼ÇȦ 17:20~17:30 Award & Closing ()